Epinephrine Bitartrate

CHEMBL1256958 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
333.3 g/mol
LogP
Phase
4

The bitartrate salt form of epinephrine, this medication rapidly reverses severe allergic reactions by opening airways and raising blood pressure. The salt form is used in specific injectable and ophthalmic preparations.

分子量

333.2900 g/mol

TPSA

188.00 Ų

治療領域

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CNC[C@H](O)c1ccc(O)c(O)c1.O=C(O)C(O)C(O)C(=O)O

InChI

InChI=1S/C9H13NO3.C4H6O6/c1-10-5-9(13)6-2-3-7(11)8(12)4-6;5-1(3(7)8)2(6)4(9)10/h2-4,9-13H,5H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t9-;/m0./s1

Molecular Formula

C13H19NO9

HBD / HBA

8 / 10

回転可能結合数

6

重原子数

23

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

The bitartrate salt form of epinephrine, this medication rapidly reverses severe allergic reactions by opening airways and raising blood pressure. The salt form is used in specific injectable and ophthalmic preparations.

Yes, Epinephrine Bitartrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1256958. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5815. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.